she lost 120 pounds, more than a third of her body weight, after starting the drug in 2022
This finding has clinical relevance for: Diabetic ulcers Pressure sores Surgical wound dehiscence Radiation-induced skin damage Chemical and thermal burns In practice, BPC-157 can be administered topically (in compounded creams), locally (via injection into wound margins), or systemically (subcutaneous injection) depending on the wound type and location
IGF-1 and Diabetes Theres been a lot of interest in the role of IGF-1 in diabetes because of its structural and functional similarities to insulin
Here's what happens after stopping GLP-1 weight-loss meds: Continued #weight loss for 1-2 months Then regain over next 4 months The more weight lost, the greater the regain From new analysis: pubmed.ncbi.nlm.nih.gov/40691794 Here's what happens after stopping GLP-1 weight-loss meds: Continued #weight loss for 1-2 months Then regain over next 4 months The more weight lost, the greater the regain From new analysis: pubmed.ncbi.nlm.nih.gov/40691794 Join the conversation
Tirzepatide for Medical Weight Loss at En Vogue IV Therapy & Wellness Tirzepatide is a groundbreaking medication that offers dual benefits for weight loss and blood sugar regulation